Canbi Pharma Tech Limited

10 Leading APIs Manufacturers in China

Sep 24, 2025

Introduction to APIs

Active Pharmaceutical Ingredients (APIs) are the key components in pharmaceutical products that are responsible for the therapeutic effects. They are the raw materials used in the production of drugs, and their quality and purity directly impact the safety and efficacy of the final pharmaceutical products. China has emerged as a global leader in API manufacturing, with a large number of companies producing high - quality APIs to meet both domestic and international demands. These manufacturers benefit from advanced technology, cost - effective production processes, and strict quality control systems.


1. Canbi Pharma Tech Limited

Company Introduction

Canbi Pharma Tech Limited is a forward - thinking company in the field of API manufacturing. It is dedicated to research, development, production, and sales of high - quality APIs. The company has a modern R & D center staffed with a team of experienced scientists and researchers. These professionals are constantly exploring new synthesis methods and improving the quality of existing APIs.


The production facilities of Canbi Pharma Tech Limited are state - of - the - art, equipped with advanced production equipment and strict quality control systems. The company adheres to international quality standards such as Good Manufacturing Practice (GMP), which ensures that the APIs produced are of high purity and quality. Canbi Pharma Tech Limited also places great emphasis on environmental protection in its production processes, using clean and sustainable production technologies.


In terms of market reach, Canbi Pharma Tech Limited has established a wide - ranging sales network both in China and overseas. It exports its APIs to many countries and regions, including Europe, North America, and Asia. The company has built long - term partnerships with numerous pharmaceutical companies, providing them with reliable API supply.


APIs Features and Company Advantages

  • Advanced R & D Capabilities: Canbi Pharma Tech Limited invests a significant amount of resources in research and development. This allows the company to develop new APIs and improve the production processes of existing ones. For example, the company has successfully developed several patented synthesis methods for some complex APIs, which not only improve the yield but also enhance the purity of the products.
  • Strict Quality Control: The company's quality control system is in line with international standards. Every batch of APIs undergoes multiple quality inspections from raw material procurement to the final product. This ensures that the products meet the strict requirements of customers and regulatory authorities.
  • Sustainable Production: Canbi Pharma Tech Limited is committed to sustainable development. It uses environmentally friendly production technologies and reduces waste and pollution in the production process. This not only helps to protect the environment but also meets the growing demand of customers for sustainable products.
  • Global Market Presence: With its wide - ranging sales network, Canbi Pharma Tech Limited can quickly respond to the needs of global customers. It can provide timely delivery and high - quality after - sales service, which has won the trust of many international pharmaceutical companies.
  • Website: https://www.canbipharma.com/


2. Zhejiang Hisun Pharmaceutical Co., Ltd.

Company Introduction

Zhejiang Hisun Pharmaceutical Co., Ltd. is a well - known pharmaceutical company in China with a long history of API manufacturing. It was founded in 1956 and has since grown into a large - scale enterprise integrating R & D, production, and sales. The company has a comprehensive product portfolio, including APIs for anti - infectives, anti - tumor drugs, and cardiovascular drugs.


Hisun Pharmaceutical has a strong R & D team composed of hundreds of professionals. The company continuously invests in R & D to develop new APIs and improve the quality of existing products. It has established multiple R & D centers at home and abroad, which are engaged in cutting - edge research in the field of APIs.


The production base of Hisun Pharmaceutical is large - scale and modern. It has advanced production equipment and a strict quality management system. The company has obtained multiple international certifications, such as FDA approval in the United States and EMA approval in the European Union, which indicates its high - quality production standards.


In the market, Hisun Pharmaceutical is a leading player both in China and globally. It exports its APIs to more than 100 countries and regions, and has established long - term stable cooperation relationships with many well - known pharmaceutical companies around the world.


APIs Features and Company Advantages

  • Diverse Product Portfolio: Hisun Pharmaceutical offers a wide range of APIs, covering multiple therapeutic areas. This allows the company to meet the different needs of customers and reduces the risk associated with relying on a single product. For example, in the anti - infective field, the company produces various antibiotics APIs, which have a high market share both at home and abroad.
  • Strong R & D Strength: The company's large - scale R & D team and multiple R & D centers enable it to keep up with the latest trends in the pharmaceutical industry. It can quickly develop new APIs in response to emerging diseases and market demands. For instance, during the COVID - 19 pandemic, Hisun Pharmaceutical actively participated in the research and development of related APIs.
  • International Certification: The company's compliance with international regulations and certifications such as FDA and EMA approval gives it a competitive edge in the global market. It can enter the high - end markets of developed countries more easily and gain the trust of international customers.
  • Cost - Effective Production: Hisun Pharmaceutical has optimized its production processes over the years, achieving economies of scale. This enables the company to produce APIs at a relatively low cost while maintaining high quality, which is very attractive to customers.


3. North China Pharmaceutical Group Corporation

Company Introduction

North China Pharmaceutical Group Corporation is one of the earliest and largest pharmaceutical enterprises in China. It was established in 1953 and has a long - standing reputation in the API manufacturing industry. The company has a complete industrial chain, from raw material cultivation to API production and finished drug manufacturing.


In terms of R & D, North China Pharmaceutical Group Corporation has a strong R & D institution. It focuses on the research and development of new APIs, especially in the fields of antibiotics and traditional Chinese medicine - derived APIs. The company also cooperates with many domestic and foreign research institutions to promote technological innovation.


The production facilities of North China Pharmaceutical Group Corporation are advanced and cover a large area. The company adheres to strict quality control from the selection of raw materials to the final product inspection. It has a series of quality management systems in place to ensure the safety and efficacy of its APIs.


The company has a wide market share in China and also exports its products to many countries in Asia, Africa, and South America. It has established a good brand image both at home and abroad, and is committed to providing high - quality APIs to the global pharmaceutical market.


APIs Features and Company Advantages

  • Complete Industrial Chain: The company's complete industrial chain gives it more control over the production process. It can ensure the quality and supply of raw materials, which is crucial for API production. For example, in the cultivation of raw materials for traditional Chinese medicine - derived APIs, the company can strictly control the quality of the raw materials from the source.
  • Long - Standing Reputation: With a history of more than 60 years, North China Pharmaceutical Group Corporation has built a good reputation in the industry. Customers trust the quality and reliability of its APIs, which is an important intangible asset for the company.
  • Focus on Traditional Chinese Medicine - Derived APIs: In addition to traditional chemical APIs, the company has a unique advantage in the research and development of traditional Chinese medicine - derived APIs. It combines traditional Chinese medicine theory with modern pharmaceutical technology, which is in line with the growing global demand for natural and traditional medicine - based APIs.
  • Strong R & D Cooperation: The company's cooperation with domestic and foreign research institutions provides it with access to the latest research results and technologies. This helps the company to continuously improve its API products and develop new ones.


4. Jiangsu Hengrui Medicine Co., Ltd.

Company Introduction

Jiangsu Hengrui Medicine Co., Ltd. is a leading innovative pharmaceutical company in China. Although it is well - known for its innovative drugs, it also has a strong presence in the API manufacturing field. The company was founded in 1970 and has grown into a large - scale enterprise with a high - tech R & D center and modern production facilities.


Hengrui Medicine has a world - class R & D team that focuses on the development of new APIs for anti - tumor, anti - inflammatory, and other therapeutic areas. The company invests a large amount of money in R & D every year, and many of its R & D achievements have reached the international advanced level.


The production base of Hengrui Medicine is equipped with the most advanced production equipment and strict quality control systems. The company adheres to the highest international quality standards in API production, and its products are widely recognized in the global market.


In the market, Hengrui Medicine's APIs are not only supplied to its own finished drug production but also sold to many other pharmaceutical companies at home and abroad. It has a high - end customer base and is committed to providing high - quality and innovative APIs.


APIs Features and Company Advantages

  • Innovative R & D: Hengrui Medicine's strong R & D capabilities enable it to develop innovative APIs. For example, in the anti - tumor field, the company has developed several new APIs with unique mechanisms of action, which have shown good therapeutic effects in clinical trials.
  • High - Quality Standards: The company adheres to strict international quality standards in API production. Its quality control system covers every aspect of the production process, from raw material inspection to final product release. This ensures that the APIs produced are of the highest quality.
  • Integration of API and Finished Drug Production: The integration of API and finished drug production allows the company to better control the quality and cost of the final products. It can optimize the production process and ensure the consistency between APIs and finished drugs.
  • Global Market Recognition: Hengrui Medicine's APIs have been recognized in the global market. The company has established a good reputation among international customers, which helps it to expand its market share and promote the internationalization of its products.


5. Shandong Xinhua Pharmaceutical Co., Ltd.

Company Introduction

Shandong Xinhua Pharmaceutical Co., Ltd. was founded in 1943 and is one of the oldest pharmaceutical companies in China. It has a long - standing experience in API manufacturing and is a well - known API manufacturer both at home and abroad.


The company has a large - scale R & D center that focuses on the research and development of new APIs and the improvement of existing production processes. It has a team of experienced R & D personnel who are constantly working on technological innovation.


Shandong Xinhua Pharmaceutical's production facilities are modern and comply with international quality standards. The company has obtained multiple international certifications, which indicates its high - quality production level. It has a wide range of API products, including APIs for analgesics, anti - histamines, and other therapeutic areas.


In the market, the company exports its APIs to more than 50 countries and regions. It has established long - term cooperation relationships with many pharmaceutical companies, and its products are well - received in the international market.


APIs Features and Company Advantages

  • Long - Term Experience: With more than 70 years of experience in API manufacturing, Shandong Xinhua Pharmaceutical has accumulated rich production experience and technical know - how. This allows the company to produce high - quality APIs with stable quality.
  • Comprehensive R & D: The company's R & D center is engaged in comprehensive research and development activities. It not only focuses on the development of new APIs but also on the improvement of existing production processes to increase efficiency and reduce costs.
  • International Certification: The company's international certifications such as GMP, FDA, and EMA approval give it an advantage in the global market. It can meet the strict requirements of international customers and regulatory authorities.
  • Stable Supply Capacity: Shandong Xinhua Pharmaceutical has a large - scale production base and a stable supply chain. This ensures that it can provide a stable supply of APIs to customers, which is very important for pharmaceutical companies that rely on a continuous supply of raw materials.


6. Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.

Company Introduction

Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. is a large - scale pharmaceutical group in China. It has a long history and a wide range of business in the pharmaceutical field, including API manufacturing. The company was established through the integration of multiple pharmaceutical enterprises in Guangzhou, and it has a strong comprehensive strength.


In terms of R & D, Guangzhou Baiyunshan Pharmaceutical Holdings has a diversified R & D system. It not only focuses on the research and development of chemical APIs but also on traditional Chinese medicine - related APIs. The company has a team of experts in both fields, which enables it to develop a variety of API products.


The production base of the company is large - scale and modern. It has advanced production equipment and a strict quality management system. The company adheres to the highest quality standards in API production, and its products are widely used in the domestic and international pharmaceutical markets.


The company has a wide market network both in China and overseas. It has established long - term cooperation relationships with many pharmaceutical companies, and its APIs are well - known for their quality and reliability.


APIs Features and Company Advantages

  • Diversified R & D Focus: The company's diversified R & D focus on both chemical and traditional Chinese medicine - related APIs gives it a unique advantage. It can meet the different needs of customers in different markets. For example, in the domestic market, there is a large demand for traditional Chinese medicine - derived APIs, while in the international market, chemical APIs are also in high demand.
  • Comprehensive Strength: As a large - scale pharmaceutical group, Guangzhou Baiyunshan Pharmaceutical Holdings has comprehensive strength in terms of R & D, production, and marketing. It can integrate resources effectively and promote the development of its API business.
  • Brand Advantage: The company has a well - known brand in the pharmaceutical industry. Customers trust the quality and safety of its APIs, which helps the company to expand its market share and establish long - term cooperation relationships.
  • Market Network: The company's wide market network allows it to quickly respond to market changes and customer needs. It can provide timely delivery and high - quality after - sales service to its customers.


7. Tianjin Tasly Pharmaceutical Co., Ltd.

Company Introduction

Tianjin Tasly Pharmaceutical Co., Ltd. is a leading enterprise in the field of traditional Chinese medicine modernization. Although it is mainly known for its traditional Chinese medicine products, it also has a significant presence in the API manufacturing of traditional Chinese medicine - derived APIs.


The company has a state - of - the - art R & D center that focuses on the research and development of traditional Chinese medicine - derived APIs. It combines traditional Chinese medicine theory with modern scientific research methods to develop high - quality APIs. The R & D team of Tasly Pharmaceutical consists of experts in traditional Chinese medicine, pharmacy, and related fields.


The production base of Tasly Pharmaceutical is equipped with advanced extraction, purification, and production equipment for traditional Chinese medicine - derived APIs. The company adheres to strict quality control from the selection of traditional Chinese medicine raw materials to the final API product. It has established a complete quality management system in line with international standards.


In the market, Tasly Pharmaceutical's traditional Chinese medicine - derived APIs are not only supplied to its own product lines but also sold to many other pharmaceutical companies at home and abroad. The company is committed to promoting the internationalization of traditional Chinese medicine - derived APIs.


APIs Features and Company Advantages

  • Expertise in Traditional Chinese Medicine - Derived APIs: The company's focus on traditional Chinese medicine - derived APIs gives it a unique advantage. It has in - depth knowledge of traditional Chinese medicine theory and modern extraction and purification technologies, which enables it to produce high - quality traditional Chinese medicine - derived APIs.
  • Modern R & D Approach: Tasly Pharmaceutical combines traditional Chinese medicine theory with modern scientific research methods. This approach helps the company to develop more effective and standardized traditional Chinese medicine - derived APIs, which is in line with the international market demand for traditional Chinese medicine products.
  • Strict Quality Control: The company's strict quality control system ensures the safety and efficacy of its traditional Chinese medicine - derived APIs. From the selection of raw materials to the final product inspection, every step is carefully monitored to meet the highest quality standards.
  • Internationalization Strategy: Tasly Pharmaceutical is actively promoting the internationalization of traditional Chinese medicine - derived APIs. It participates in international exhibitions and cooperation projects, which helps to increase the international recognition of its products.


8. Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Company Introduction

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a large - scale pharmaceutical group with a wide range of business in the pharmaceutical field, including API manufacturing. The company was founded in 1992 and has since grown into a well - known enterprise both in China and globally.


Fosun Pharmaceutical has a strong R & D team that focuses on the research and development of new APIs for various therapeutic areas, such as anti - tumor, anti - infectious, and autoimmune diseases. The company invests a large amount of resources in R & D to keep up with the latest trends in the pharmaceutical industry.


The production facilities of Fosun Pharmaceutical are modern and comply with international quality standards. The company has multiple production bases both in China and overseas, which ensures a stable supply of APIs. It has a strict quality management system in place to ensure the quality of its products.


In the market, Fosun Pharmaceutical's APIs are sold to many pharmaceutical companies around the world. The company has established a global sales network and is committed to providing high - quality APIs to meet the diverse needs of the global pharmaceutical market.


APIs Features and Company Advantages

  • Global Vision: Fosun Pharmaceutical has a global vision in its API business. It has established production bases and R & D centers overseas, which allows it to better understand and meet the needs of the international market. For example, its overseas production bases can directly supply APIs to local pharmaceutical companies, reducing transportation costs and time.
  • Diversified Therapeutic Areas: The company's R & D focus on multiple therapeutic areas gives it a competitive edge. It can develop a variety of APIs to meet the different needs of customers in the global pharmaceutical market. For instance, in the field of anti - tumor APIs, the company has made significant progress in recent years.
  • Strong R & D Investment: Fosun Pharmaceutical's large - scale investment in R & D enables it to develop new and innovative APIs. The company is constantly exploring new synthesis methods and technologies to improve the quality and efficiency of API production.
  • Global Sales Network: The company's global sales network allows it to quickly respond to market changes and customer needs. It can provide timely delivery and high - quality after - sales service to its customers around the world.


9. Hubei Changjiang Pharmaceutical Co., Ltd.

Company Introduction

Hubei Changjiang Pharmaceutical Co., Ltd. is a professional API manufacturer in China. It has a long - term focus on the production of APIs for anti - infectives, vitamins, and other therapeutic areas.


The company has a well - equipped R & D center that is dedicated to the research and development of new APIs and the improvement of existing production processes. The R & D team consists of a group of experienced professionals who are constantly working on technological innovation.


Hubei Changjiang Pharmaceutical's production facilities are modern and comply with international quality standards. The company has obtained multiple international certifications, which indicates its high - quality production level. It has a stable production capacity and can ensure a continuous supply of APIs to its customers.


In the market, the company exports its APIs to many countries and regions, especially in Asia, Europe, and America. It has established long - term cooperation relationships with many pharmaceutical companies, and its products are well - received in the international market.


APIs Features and Company Advantages

  • Focus on Specific Therapeutic Areas: The company's focus on specific therapeutic areas such as anti - infectives and vitamins allows it to have in - depth knowledge and expertise in these fields. It can produce high - quality APIs with a high degree of specialization.
  • Technological Innovation: The company's R & D center is constantly working on technological innovation. It has developed several advanced production processes for its APIs, which improve the yield and quality of the products.
  • International Certification: The company's international certifications give it an advantage in the global market. It can meet the strict requirements of international customers and regulatory authorities, which helps to expand its market share.
  • Stable Supply Capacity: Hubei Changjiang Pharmaceutical has a stable production capacity and a reliable supply chain. This ensures that it can provide a continuous supply of APIs to its customers, which is crucial for pharmaceutical companies that rely on a stable raw material supply.


10. Sichuan Kelun Pharmaceutical Co., Ltd.

Company Introduction

Sichuan Kelun Pharmaceutical Co., Ltd. is a well - known pharmaceutical company in China. It has a comprehensive business in the pharmaceutical field, including API manufacturing. The company was founded in 1993 and has since grown into a large - scale enterprise.


Kelun Pharmaceutical has a strong R & D team that focuses on the research and development of new APIs for various therapeutic areas, such as infusion solutions, antibiotics, and anti - tumor drugs. The company invests a significant amount of resources in R & D to develop innovative API products.


The production base of Kelun Pharmaceutical is large - scale and modern. It has advanced production equipment and a strict quality management system. The company adheres to international quality standards in API production and has obtained multiple international certifications.


In the market, Kelun Pharmaceutical's APIs are widely used in its own finished drug products and are also sold to many other pharmaceutical companies at home and abroad. The company is committed to providing high - quality APIs to the global pharmaceutical market.


APIs Features and Company Advantages

  • Diversified Product Portfolio: The company's diversified product portfolio in API manufacturing allows it to meet the different needs of customers. It can produce APIs for various therapeutic areas, which reduces the risk associated with relying on a single product.
  • Strong R & D Investment: Kelun Pharmaceutical's significant investment in R & D enables it to develop new and innovative APIs. The company is constantly exploring new synthesis methods and technologies to improve the quality and efficiency of API production.
  • Quality Assurance: The company's strict quality management system and international certifications ensure the quality and safety of its APIs. Customers can trust the reliability of its products, which is an important factor in the pharmaceutical industry.
  • Integration with Finished Drug Production: The integration of API manufacturing with finished drug production gives the company more control over the production process. It can optimize the quality and cost of the final products and ensure the consistency between APIs and finished drugs.


Conclusion

China's API manufacturing industry has witnessed remarkable development in recent years, and the ten companies mentioned above are among the leading players in this field. These companies have their own unique advantages, such as advanced R & D capabilities, strict quality control, diverse product portfolios, and strong market presence.


Canbi Pharma Tech Limited stands out with its advanced R & D and sustainable production. Zhejiang Hisun Pharmaceutical Co., Ltd. benefits from its diverse product portfolio and international certifications. North China Pharmaceutical Group Corporation has a complete industrial chain and a long - standing reputation. Jiangsu Hengrui Medicine Co., Ltd. is known for its innovative R & D in high - end APIs. Shandong Xinhua Pharmaceutical Co., Ltd. has long - term experience and stable supply capacity. Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. has a diversified R & D focus and brand advantage. Tianjin Tasly Pharmaceutical Co., Ltd. is a leader in traditional Chinese medicine - derived APIs. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has a global vision and strong R & D investment. Hubei Changjiang Pharmaceutical Co., Ltd. focuses on specific therapeutic areas and technological innovation. Sichuan Kelun Pharmaceutical Co., Ltd. has a diversified product portfolio and integration with finished drug production.


These companies not only meet the domestic demand for APIs but also play an important role in the global API market. With continuous investment in R & D, improvement of production processes, and strict quality control, they are expected to further strengthen their positions in the global pharmaceutical industry and contribute to the development of the global pharmaceutical market.


goTop